News & HighlightsNews
Mitochondrial antioxidant found to drive breast cancer metastasis
Researchers have learned that the antioxidant glutathione, when operating inside mitochondria, is a key factor enabling tumors to spread from the breast to the lung.
Immunotherapy drug eliminates aggressive cancers in clinical trial
The researchers demonstrate that an engineered antibody improves a class of drugs that has struggled to make good on its early promise.
New tool helps predict antibiotic resistance
Using the novel platform could help pharmaceutical companies design longer lasting drugs.
How ant queens are made
New research offers fresh insight into how different morphological types and social roles emerge in ant societies, confirming that size is coupled to caste, with genes ultimately deciding how size and caste are related within the context of a colony.
How new genes get switched on
After nearly a decade of cataloguing evolutionarily young genes, complementary studies are the first to demonstrate how they are regulated and expressed.
This brain circuit drives the urge to mate. Except when it doesn’t.
Scientists discovered an identical neural circuit that operates differently in male and female mice.
Restricting an amino acid found in common foods could potentially speed up wound healing
Research shows low levels of the amino acid serine trigger a process that turns hair follicle stem cells into skin repair specialists—and that diet may have a role to play.
Rockefeller team finds flawed data in recent study relevant to coronavirus antiviral development
New research demonstrates that a previously published structure and mechanism for RNA capping at work in coronaviruses is incorrect, with potentially sweeping implications for the quest to develop drugs targeting these pathogens.
Why scientists and policy experts are trying to map the genomes of every animal, plant and fungal species in the US
The Vertebrate Genomes Project has set its sights on creating high-quality reference genomes to help answer some of science’s biggest questions.
How an Alzheimer's peptide and a blood protein may combine to drive early disease pathology
New research suggests that amyloid-beta (Aβ) oligomers and the vascular protein fibrinogen may, when forming a complex, contribute to Alzheimer's disease.
View
View